Y.A. Abuodeh

Immunotherapy and targeted therapy combinations in metastatic breast cancer

Breast cancer statistics, 2019

A view on drug resistance in cancer

T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

Inflammation and tumor progression: signaling pathways and targeted intervention

Mortality due to cancer treatment delay: systematic review and meta-analysis

Macrophages as regulators of tumour immunity and immunotherapy

Radiotherapy: Changing the Game in Immunotherapy

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors

Using immunotherapy to boost the abscopal effect

Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Hepatocellular carcinoma

Prognostic Value of the Albumin-Bilirubin Grade for the Prediction of Post-Hepatectomy Liver Failure: A Systematic Review and Meta-Analysis

Mertk on tumor macrophages is a therapeutic target to prevent tumor recurrence following radiation therapy

Reactive Oxygen Species (ROS)-Based Nanomedicine

Association of Treatment Delays With Survival for Patients With Head and Neck Cancer

Using the Albumin-Bilirubin (ALBI) grade as a prognostic marker for radioembolization of hepatocellular carcinoma

Treatment delays, race, and outcomes in head and neck cancer

Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy

Systematic review of case reports on the abscopal effect